News
-
-
-
COMMUNIQUÉ DE PRESSE
Immunic to Participate in Scientific and Medical Conferences in April
Immunic, Inc. to participate in scientific and medical conferences in April. Presentation on vidofludimus calcium for treating multiple sclerosis at the Neuroimmunology Drug Development Summit and AAN Annual Meeting -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Immunic Strengthens Its Board of Directors with the Appointment of Seasoned Biopharmaceutical Executive Jon Congleton
Immunic strengthens its Board of Directors with the appointment of seasoned biopharmaceutical executive Jon Congleton on March 31, 2026, to support the development of novel oral therapies for neurologic diseases -